Friday, December 15, 2006

Research Indicates Breast Cancer Cells May Be Fought With Vitamin E Precursor

Medical data indicates that approximately 30 percent of breast cancers have high levels of a HER2, a human epidermal growth factor receptor. Research conducted by Griffith University's School of Medicine has found that these breast cancer cells may be fought with a precursor of vitamin E. The HER2 feature found in this types of cancer is resistant to many treatments such as chemotherapy. The experimental research study was done on mice. Results show that pro-vitamin E or alpha-tocopheryl succinate (alpha-TOS) can reduce the number of these tumors. --Click the title of this post to read the full article from its source--

Labels: ,

/* WebRing Code */